CANCER GENE THERAPY Journal

publication venue for

Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy 2021
Tumor suppressor immune gene therapy to reverse immunotherapy resistance 2021
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials 2020
PIK3CA gene aberrancy and role in targeted therapy of solid malignancies 2020

category

BIOTECHNOLOGY & APPLIED MICROBIOLOGY Category
GENETICS & HEREDITY Category
MEDICINE, RESEARCH & EXPERIMENTAL Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

0929-1903

Electronic International Standard Serial Number (EISSN)

1476-5500

journal abbreviation

CANCER GENE THER